A Study of Temodar With PCI-24781 for Patients With Recurrent Glioma

Conditions:   Recurrent High Grade Glioma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Glioblastoma;   Gliosarcoma Interventions:   Drug: PCI 24781;   Drug: Temozolomide Sponsors:   University of Nebraska;   Xynomic Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials